102
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Comparison of Real-World Dose and Consumption for Two Extended Half-Life Recombinant Factor VIII Products for the Treatment of Hemophilia A in the United States

, ORCID Icon &
Pages 517-524 | Received 21 Mar 2022, Accepted 30 Aug 2022, Published online: 24 Sep 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.